Non Small Cell Lung Cancer

β-elemene：400-600mg + 5%GS 500ml,ivgtt,qd, continuously 45days

β-elemene

EGFR-TKIs(Erlotinib, Gefitinib and Icotinib) as usual

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

progression free survival ratio in 12 week

Yunpeng Liu

Director of Department of Medical Oncology,The First Hospital of China Medical University Affiliation: China Medical University, China

China Medical University, China

The First Affiliated Hospital of Dalian Medical University

The Second Affiliated Hospital of Dalian Medical University

Liaoning Tumor Hospital & Institute

Shengjing Hospital

General Hospital of Shenyang Military Region

2,000 mg turmeric per day - supplied by Banyan® Botanicals )
o Each tablet contains 500 mg of Turmeric (Curcuma longa). Subjects will take 2 tablets twice per day, with a total daily dose of 2,000 mg.

• 2,000 mg Healthy Skin™ Tablets, contains:
Turmeric (Curcuma longa) - 50 mg/tablet
Hemidesmus Indicus root (Anantamul)
Indian Madder root
Neem leaf
Gotu Kola leaf
Indian TInospora stem
Amla fruit
Licorice root
Phyllanthus Amarus herb Each tablet contains 500mg total of the above herbs. There is 50 mg of Turmeric in each Healthy Skin ™ tablet. Subjects will take 2 tablets twice per day, which will be a total daily dose of 200 mg of Turmeric. This is comparable to the daily amount of Turmeric in many commercially-available Turmeric supplements; therefore, it is valuable to compare this formulation to the turmeric-only tablets.

Supplement appearing similar to those in the turmeric and curcumin groups, supplied by Banyan® Botanicals
Ingredients (all organic): Placebo ingredients: Rice hulls concentrate, Maltodextrin, Micro Crystalline Cellulose, Beet Root Powder, Dutch coco powder
Dose: subjects in this group will take 2 tablets twice per day

Skin Inflammation

Turmeric

Turmeric-containing combination tablet

Placebo tablets

University of California, Davis Dermatology Clinical Trials Unit

Turmeric and Turmeric-containing Tablets and Sebum Production

Pilot Study on the Effects of Oral Turmeric and Turmeric-containing Tablets on Sebum Production

The investigators will use Sebutapes placed on the forehead to measure facial sebum production for 60 minutes at baseline and after 4 weeks. The tapes will collect the facial sebum produced during that time.

University of California, Davis

Hyperprolactinoma

Curcumin is prescribed to new cases of hyperprolactinoma

curcuma comosa/kanceri

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

Turmeric and Turmeric-containing Tablets and Sebum Production

Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients

Baza e të dhënave më e plotë e bimëve medicinale e mbështetur nga shkenca